Skip to main content
Premium Trial:

Request an Annual Quote

PhenoBiome Inks US Distribution Deal With Genetic Direction for Gut Microbiome Assay Service

NEW YORK — PhenoBiome said on Thursday that it has signed a nonexclusive US distribution deal for its direct-to-consumer GxGutHealth gut microbiome assay service with Genetic Direction.

According to PhenoBiome, GxGutHealth assesses an individual's gut microbiome and provides a report that can guide behavioral and other health interventions to improve gut health. The assays are processed by Eurofins subsidiary Clinical Enterprise.

On its website, PhenoBiome says its platform converts taxonomic signatures from 16S sequence data and gene lists into microbiome-wide quantitative functional capabilities. It deduces metabolic phenotypes reflecting the presence or absence of a pathway in all microbes from parts lists using a genome-based in silico reconstruction method.

Under the terms of the deal, Genetic Direction, a Dallas-based distributor of consumer genetic testing products, will offer GxGutHealth through its 900 affiliates throughout the US. Additional terms were not disclosed.

"Through more than a decade of research, our science team has identified the specific bacteria that contribute to more than 100 physiological functions in the human body and built a test that provides a complete and accurate picture of an individual patient's gut microbiome," Pavel Novichkov, PhenoBiome's cofounder and chief technology officer, said in a statement.

Palm Springs, California-based PhenoBiome also said that it has begun collaborating with an undisclosed animal health company to apply its gut microbiome technology to animal health and that it is planning to expand into additional markets including personalized prebiotics, probiotics, and food supplements.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.